A Agilent Technologies Inc.

Agilent Launches New Advanced Dilution System to Increase Lab Efficiency

Agilent Technologies Inc. (NYSE: A) today announced the launch of the , the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory.

The Agilent ADS 2 is an intelligent autodilutor designed to enhance laboratory workflows. Designed to integrate seamlessly with Agilent autosamplers, ICP-OES and ICP-MS instruments and software, it offers a fully integrated, single-supplier automated solution.

As one of the most trusted brands in the analytical instrumentation market, Agilent worked with a wide range of customers to address key barriers to autodilution adoption. The result is an easy to install, highly efficient and robust solution for production environments, utilizing unique flow path technology to optimize the speed of analysis for both diluted and undiluted samples, and the same software as the instrument to ensure consistency and traceability in data handling and reporting.

“We understand that the ability to enhance lab productivity without compromising quality or profitability is of utmost importance to our customers,” stated Keith Bratchford, vice president and general manager of Agilent's Atomic Spectroscopy Division. “Agilent’s comprehensive automation system establishes us as the exclusive provider capable of meeting the needs of routine food, environmental, and pharmaceutical testing laboratories. Furthermore, the ADS 2 will have significant applications in the advanced materials market, particularly in battery research, differentiating us from our competitors.”

Agilent’s single-vendor approach offers a seamless and attractive alternative for our valued customers, resulting in simplified data management, and increased productivity.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on and .

EN
01/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Agilent Technologies, Inc.: Key facts and statistics - fiscal 2025

A summary company profile, detailing Agilent Technologies, Inc.’s business operations and financial highlights.

Agilent Technologies, Inc. - October 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Agilent Technologies, Inc.: Update to credit analysis

Our credit view of this issuer reflects its low financial leverage, against its high proportion of revenue from costly equipment sales, which has exposure to cyclical demand fluctuations

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 December 2025 in which we reassessed the appropriateness of the ratings in th...

Agilent Technologies Inc: 1 director

A director at Agilent Technologies Inc sold 2,600 shares at 149.812USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch